Concepedia

Publication | Open Access

Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma

DOIFull Paper Access

43

Citations

11

References

2020

Year

Ghassan K. Abou‐Alfa, Robert J. Mayer, Alan P. Venook, Allison F. O’Neill, Muhammad Shaalan Beg, Michael P. LaQuaglia, T. Peter Kingham, Rachel Kobos, Olca Baştürk, Cameron Brennan,
The Oncologist

Abstract

The study provided no rationale for further studying ENMD-2076 as a single agent in FLC.

References

YearCitations

Page 1